Literature DB >> 35243760

Vanadium(IV) oxide affects embryonic development in mice.

Lucila Álvarez-Barrera1, Juan José Rodríguez-Mercado1, Rodrigo Aníbal Mateos-Nava1, Nydia Angélica Ocampo-Aguilera1, Mario Agustín Altamirano-Lozano1.   

Abstract

Vanadium(V) and vanadium(IV) are the predominant redox forms present in the environment, and epidemiological studies have reported that prenatal vanadium exposure is associated with restricted fetal growth and adverse birth outcomes. However, data about the toxic effects of vanadium(IV) oxide (V2 O4 ) on the development of mammals are still limited. Therefore, in this work, 4.7, 9.4, or 18.7 mg/kg body weight/injection/day V2 O4 was administered through an intraperitoneal (ip) injection to pregnant mice from gestational days 6 to 16. The results showed that V2 O4 produced maternal and embryo-fetal toxicity and external abnormalities in the offspring, such as malrotated and malpositioned hind limbs, hematomas and head injuries. Moreover, the skeletons of the fetuses presented reduced ossification of the cranial bones, including the frontal and parietal bones, corresponding to head injuries observed in the external assessment of the fetuses. These results demonstrate that administration of V2 O4 to pregnant females in the organogenesis period adversely affects embryonic development.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  abnormalities in mice offspring; embryo and fetotoxicity; maternal toxicity; pregnant mice; reduced ossification of the bones; vanadium(IV)

Year:  2022        PMID: 35243760     DOI: 10.1002/tox.23508

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  1 in total

1.  Biodistribution of Vanadium Dioxide Particles in Mice by Consecutive Gavage Administration: Effects of Particle Size, Dosage, and Health Condition of Mice.

Authors:  Shi-Ying Tan; Xing-Zhu Chen; Aoneng Cao; Haifang Wang
Journal:  Biol Trace Elem Res       Date:  2022-08-19       Impact factor: 4.081

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.